A Phase III Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome

NCT02503189 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Dry Eye With Sjögren's Syndrome

Interventions

DRUG: KCT-0809 ophthalmic solution
DRUG: Placebo

Sponsor

Kissei Pharmaceutical Co., Ltd.